Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study

References

• Liao Y Xiang Y Zhou Z Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection Front Med 2012 6 3 243 247 22843304
   PubMedGoogle Scholar
• Guglielmi C Palermo A Pozzilli P Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy Diabetes Metab Res Rev 2012 28 Suppl 2 40 46
   Web of Science ®Google Scholar
• Pipi E Marketou M Tsirogianni A Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus World J Diabetes 2014 5 4 505 510 25126396
   PubMedGoogle Scholar
• Tree TI Roep BO Peakman M A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop Ann NY Acad Sci 2006 1079 9 18 17130526
   PubMed Web of Science ®Google Scholar
• Yang Z Zhou Z Huang G The CD4+ regulatory T-cells is decreased in adults with latent autoimmune diabetes Diabetes Res Clin Pract 2007 76 1 126 131 17005288
   PubMed Web of Science ®Google Scholar
• Salem SD1 Saif-Ali R Muniandy S Al-Hamodi Z Ismail IS Comparison of adults with insulin resistance (IR) in latent autoimmune diabetes versus IR in glutamic acid decarboxylase antibody-negative diabetes Ann Acad Med Singapore 2014 43 2 107 112 24652431
   PubMed Web of Science ®Google Scholar
• Siewko K Popławska-Kita A Telejko B Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes J Diabetes Complications 2013 27 6 593 596 23890682
   PubMed Web of Science ®Google Scholar
• Nadeau KJ Regensteiner JG Bauer TA Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function J Clin Endocrinol Metab 2010 95 2 513 521 19915016
   PubMed Web of Science ®Google Scholar
• Itariu BK Stulnig TM Autoimmune aspects of type 2 diabetes mellitus – a mini-review Gerontology 2014 60 3 189 196 24457898
   PubMed Web of Science ®Google Scholar
• Miao D Guyer KM Dong F GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes Diabetes 2013 62 12 4174 4178 23974918
   PubMed Web of Science ®Google Scholar
• Pundir CS Chawla S Determination of glycated hemoglobin with special emphasis on biosensing methods Anal Biochem 2014 444 47 56 24090871
   PubMed Web of Science ®Google Scholar
• Mendivil CO Robles-Osorio L Horton ES Hamdy O Caballero AE Young Hispanics at risk of type 2 diabetes display endothelial activation, subclinical inflammation and alterations of coagulation and fibrinolysis Diabetol Metab Syndr 2013 5 1 37 23870459
   PubMed Web of Science ®Google Scholar
• Matthews JN Altman DG Campbell MJ Royston P Analysis of serial measurements in medical research BMJ 1990 300 6719 230 235 2106931
   PubMed Web of Science ®Google Scholar
• Krause S Landherr U Agardh CD GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial Diabetes Care 2014 37 6 1675 1680 24598244
   PubMed Web of Science ®Google Scholar
• Zinman B Kahn SE Haffner SM O’Neill MC Heise MA Freed MI ADOPT Study Group Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe Diabetes 2004 53 12 3193 3200 15561950
   PubMed Web of Science ®Google Scholar
• Fukui M Nakano K Maruya E Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agents failure Clin Immunol Immunopathol 1997 85 2 182 186 9344701
   PubMedGoogle Scholar
• Vincent A Grimaldi LM Martino G Davenport C Todd I Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome J Neurol Neurosurg Psychiatry 1997 62 4 395 397 9120459
   PubMed Web of Science ®Google Scholar
• Lohmann T Hawa M Leslie RD Lane R Picard J Londei M Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus Lancet 2000 356 9223 31 35 10892762
   PubMed Web of Science ®Google Scholar
• Kronus Inc Islet cell autoimmunity Available from: http://www.kronus.com/technical/pancreas.html#GADAb Accessed March 15, 2017
   Google Scholar
• Pilia S Casini MR Cambuli VM Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis Diabet Med 2011 28 8 896 899 21749442
   PubMed Web of Science ®Google Scholar
• Cesarini PR1 Mendonça E Fernandes V Prevalence of immunologic markers (Anti-GAD and Anti-IA2) in first-degree relatives of patients with type I diabetes in the greater area of São Paulo Rev Assoc Med Bras 2003 49 4 395 400 Portuguese 14963591
   PubMedGoogle Scholar
• Langer P Tajtáková M Guretzki HJ High prevalence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in employees at a polychlorinated biphenyl production factory Arch Environ Health 2002 57 5 412 415 12641181
   PubMed Web of Science ®Google Scholar
• Unnikrishnan AG1 Singh SK Sanjeevi CB Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes Ann N Y Acad Sci 2004 1037 118 121 15699503
   PubMed Web of Science ®Google Scholar
• Wilmot-Roussel H Lévy DJ Carette C Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes Diabetes Metab 2013 39 244 249 23522731
   PubMed Web of Science ®Google Scholar
• Wang L Wang FS Gershwin ME Human autoimmune diseases: a comprehensive update J Intern Med 2015 278 4 369 395 26212387
   PubMed Web of Science ®Google Scholar
• Schwartz SS Epstein S Corkey BE Grant SF Gavin JR3rd Aguilar RB The time is right for a new classification system for diabetes: rationale and implications of the β-cell-centric classification schema Diabetes Care 2016 39 2 179 186 26798148
   PubMed Web of Science ®Google Scholar